NexgenRX Inc. (NXG : TSX-V)
Common Stock
$0.46
CAD
+0.00 (%)
Last updated: 2026-07-02
NXG
NexgenRX Inc.
Performance
1 Day
+0.00%
1 Week
-1.08%
1 Month
+4.55%
YTD
+15.00%
Key Statistics
Market Cap
$32.36M
52W High
$0.48
52W Low
$0.29
P/E Ratio
22.75
50 Day MA
$0.41
200 Day MA
$0.39
Beta
0.51
Dividend Yield
3.26%
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/2/2026 | $0.46 | $0.46 | $0.46 | $0.46 | $0.46 | 7,500 |
| 6/30/2026 | $0.46 | $0.47 | $0.45 | $0.46 | $0.46 | 151,301 |
| 6/29/2026 | $0.45 | $0.45 | $0.45 | $0.45 | $0.45 | 131,360 |
| 6/26/2026 | $0.45 | $0.45 | $0.45 | $0.45 | $0.45 | 314,084 |
| 6/25/2026 | $0.47 | $0.47 | $0.47 | $0.47 | $0.47 | 16,949 |
| 6/24/2026 | $0.47 | $0.47 | $0.47 | $0.47 | $0.47 | 19,500 |
| 6/23/2026 | $0.45 | $0.45 | $0.44 | $0.45 | $0.45 | 99,132 |
| 6/22/2026 | $0.45 | $0.47 | $0.44 | $0.47 | $0.47 | 82,557 |
| 6/19/2026 | $0.44 | $0.45 | $0.44 | $0.45 | $0.45 | 50,500 |
| 6/18/2026 | $0.43 | $0.44 | $0.43 | $0.44 | $0.44 | 255,616 |
Analyst Price Targets
Based on analyst covering NXG
Wall Street analysts forecast NXG stock price to rise 823.9% over the next 12 months.
Consensus
No RatingAvg. Target
C$4.25
+823.9% Upside
Current Price
C$0.46
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NXG's historical volatility
30-Day Vol
76.3%
Annualized
90-Day Vol
85.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.55
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.49 | C$0.38 โ C$0.64 |
| 60 trading days | C$0.52 | C$0.36 โ C$0.75 |
| 90 trading days | C$0.55 | C$0.35 โ C$0.87 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About NexgenRX Inc.
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides proprietary computer software, and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.
Financials
- Revenue (TTM)
- $18.45M
- EBITDA
- $2.90M
- Profit Margin
- 10.79%
- ROE (TTM)
- 23.51%
- EPS (Diluted)
- 0.02
- Book Value
- 0.10
Classification
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Group
- Health Care Equipment & Services
๐ฐ Recent Dividends
$0.0050
Ex: Apr 24, 2026
$0.0050
Ex: Dec 16, 2024
$0.0050
Ex: Jun 24, 2024
$0.0050
Ex: Dec 28, 2023
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE Report